0.7676
前日終値:
$0.6994
開ける:
$0.69
24時間の取引高:
249.87K
Relative Volume:
1.35
時価総額:
$58.99M
収益:
$9.53M
当期純損益:
$-44.61M
株価収益率:
-0.8435
EPS:
-0.91
ネットキャッシュフロー:
$-38.32M
1週間 パフォーマンス:
-2.24%
1か月 パフォーマンス:
+6.80%
6か月 パフォーマンス:
+1.66%
1年 パフォーマンス:
-52.32%
Cue Biopharma Inc Stock (CUE) Company Profile
CUE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
CUE
Cue Biopharma Inc
|
0.7676 | 53.75M | 9.53M | -44.61M | -38.32M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-13 | 開始されました | Jefferies | Buy |
| 2023-06-26 | 再開されました | Oppenheimer | Outperform |
| 2022-11-21 | 開始されました | Piper Sandler | Overweight |
| 2022-01-13 | 開始されました | H.C. Wainwright | Buy |
| 2022-01-03 | 開始されました | Craig Hallum | Buy |
| 2020-11-24 | 開始されました | Berenberg | Buy |
| 2020-04-09 | 開始されました | Stifel | Buy |
| 2020-01-28 | 開始されました | BTIG Research | Buy |
| 2020-01-22 | 開始されました | JMP Securities | Mkt Outperform |
すべてを表示
Cue Biopharma Inc (CUE) 最新ニュース
Historical volatility pattern of Cue Biopharma Inc. visualizedWall Street Watch & Accurate Entry/Exit Alerts - newser.com
What dividend safety score for Cue Biopharma Inc. stockJuly 2025 Sector Moves & Stepwise Entry and Exit Trade Signals - newser.com
Why Cue Biopharma Inc. (1UC) stock could be next leaderLong Setup & Weekly Top Gainers Alerts - newser.com
Is Cue Biopharma Inc. stock vulnerable to regulatory risksJuly 2025 Rallies & Intraday High Probability Alerts - newser.com
Short Interest in Cue Biopharma, Inc. (NASDAQ:CUE) Declines By 44.6% - MarketBeat
How Cue Biopharma Inc. stock reacts to global recession fearsJuly 2025 Spike Watch & Safe Entry Point Identification - newser.com
Cue Biopharma Inc. recovery potential after sell offQuarterly Profit Summary & High Accuracy Swing Trade Signals - newser.com
Live market analysis of Cue Biopharma Inc.July 2025 Action & Fast Momentum Stock Entry Tips - newser.com
How Cue Biopharma Inc. (1UC) stock stacks up against competitorsWeekly Profit Analysis & Safe Entry Zone Identification - newser.com
Is Cue Biopharma Inc. stock gaining market shareIPO Watch & Risk Managed Investment Strategies - newser.com
Is Cue Biopharma Inc. stock in correction or buying zoneWeekly Profit Summary & Weekly Top Performers Watchlists - newser.com
Can trapped investors hope for a rebound in Cue Biopharma Inc.July 2025 Summary & Daily Technical Stock Forecast Reports - newser.com
What is the fair value of Cue Biopharma Inc. stock nowPortfolio Value Summary & High Conviction Investment Ideas - newser.com
Trend analysis for Cue Biopharma Inc. this weekLong Setup & Risk Controlled Swing Alerts - newser.com
Is Cue Biopharma Inc. (1UC) stock undervalued after correctionWeekly Market Outlook & Target Return Focused Stock Picks - newser.com
Risk adjusted return profile for Cue Biopharma Inc. analyzedJuly 2025 Sector Moves & Fast Exit Strategy with Risk Control - newser.com
Using Ichimoku Cloud for Cue Biopharma Inc. technicals2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - newser.com
Full technical analysis of Cue Biopharma Inc. stockJuly 2025 EndofMonth & Safe Entry Trade Reports - newser.com
How currency fluctuations impact Cue Biopharma Inc. stockEarnings Growth Summary & Growth-Oriented Investment Plans - newser.com
Is Cue Biopharma Inc. reversing from oversold territoryWeekly Stock Report & Safe Capital Growth Trade Ideas - newser.com
Cue Biopharma Inc (CUE) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):